Literature DB >> 1116679

Bile acid metabolism in cirrhosis. IV. Characterization of the abnormality in deoxycholic acid metabolism.

T Yoshida, W C McCormick, L Swell, Z R Vlahcevic.   

Abstract

Several recent studies have demonstrated that patients with cirrhosis frequently lack deoxycholic acid in bile and plasma. In order to explain this observation, comparative experiments on the colonic absorption of deoxycholic acid and on the colonic conversion of cholic to deoxycholic acid were carried out in the cirrhotic patients with normal and very low percentages of deoxycholic acid. Deoxycholic or cholic acid (100 mg) plus 5 muc of each [14C] bile acid were administered by enema to 8 patients with and 5 without liver disease. Deoxycholic acid produced a significant increase in the percentage of biliary deoxycholic acid in patients with cirrhosis. However, the rate of appearance of 14C-deoxycholic acid in patients with cirrhosis was slower than in normal control subjects. Distribution of the 14C activity among the bile acids indicated that rehydroxylation of deoxycholic to cholic acid did not occur. The distribution of 14C activity in biliary bile acids after the rectal administration of [14C]cholic acid showed that patients with severe cirrhosis converted [14C]cholic to [14C]deoxycholic acid at a much slower rate than did cirrhotic patients with normal percentages of biliary deoxycholic acid. Feeding of cholic acid (450 mg per day) for 3 days to 4 cirrhotic patients resulted in a 2-fold increase in the percentage of biliary cholic acid, but only a small increase in the percentage of deoxycholic acid. In a separate group of 9 cirrhotic patients, fecal bile acid analysis indicated that cirrhotic patients had a significantly lower percentage of deoxycholic acid than 12 patients without liver disease; there was no significant difference in fecal lithocholic acid. The data suggest that alteration of bacterial flora and/or altered conditions for bacterial 7alpha-dehydroxylase enzyme activity in the colon could account for the virtual absence of biliary deoxycholic acid in severely cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116679

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Cirrhosis as an independent risk factor for colonic adenomas.

Authors:  S Naveau; J C Chaput; P Bedossa; T Poynard; C Pauphilet; O Ink; C Houdayer; A Aubert
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 2.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

3.  Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors.

Authors:  I Kato; A Nomura; G N Stemmermann; P H Chyou
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

4.  Diet, alcohol, and relative weight in gall stone disease: a case-control study.

Authors:  R K Scragg; A J McMichael; P A Baghurst
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

5.  Serum bile acids in the diagnosis of hepatobiliary disease.

Authors:  C R Pennington; P E Ross; I A Bouchier
Journal:  Gut       Date:  1977-11       Impact factor: 23.059

6.  Incidence of cholelithiasis among patients with cirrhosis and portal hypertension.

Authors:  H V Steinberg; W W Beckett; J L Chezmar; W E Torres; F B Murphy; M E Bernardino
Journal:  Gastrointest Radiol       Date:  1988-10

7.  Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis.

Authors:  P Di Donato; F Carubbi; M Ponz de Leon; N Carulli
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

8.  Serum, fecal and urinary bile acids in patients with mild and advanced liver cirrhosis.

Authors:  Y Amuro; T Endo; K Higashino; K Uchida; Y Yamamura
Journal:  Gastroenterol Jpn       Date:  1981

Review 9.  Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.

Authors:  Uday C Ghoshal; Deepakshi Srivastava
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Alcohol protects against cholesterol gallstone formation.

Authors:  W H Schwesinger; W E Kurtin; R Johnson
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.